Exonate is a startup based in the United Kingdom, most recent round Seed.
Exonate is a company headquartered in the United Kingdom. Its most recent tracked round is Seed.
Exonate is an early-stage biotech company developing innovative therapeutics that modify mRNA splicing, with a lead program targeting wet Age-Related Macular Degeneration in ophthalmology.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.